pH-sensitive Nanoparticles for High Loading and Efficient Delivery of Doxorubicin

Abstract

An acid-sensitive delivery system based on acylhydrazone bond was developed for high loading and efficient delivery of doxorubicin. Doxorubicin(DOX) was covalently combined with dihydrazide adipate to form acid-sensitive hydrazone bond based on Schiff base reaction, then the intermediate was covalently combined with carboxymethyl chitosan through amide bond to form polymeric prodrugs, and nanoparticles were formed through self-assembling. Moreover, the structural and particle properties of CMCS-ADH-DOX were characterized by ultraviolet visible near infrared spectrophotometry (UV), nuclear magnetic resonance spectroscopy (¹H-NMR), fourier transform infrared spectroscopy (FT-IR), dynamic light scattering (DLS), and transmission electron microscopy (TEM). The mean diameter of the self-assembled nanoparticles is 165 nm, while the morphology is a relatively uniform spherical shape. Moreover, these DOX-loaded nanoparticles showed pH-triggered drug release behavior. Compared with free DOX, CAD NPs showed lower toxic side effects in L929 cells and similar toxicity in 4T1 cells. The experimental results indicate that the CMCS-ADH-DOX nanoparticles may be used as an acid-sensitive targeted delivery system with good application prospect for cancer.

Keywords

nanoparticles / acylhydrazone bond / polymeric prodrug / acid-sensitive

References

[1] Nosrati H, Salehiabar M, Manjili H K, et al. Preparation of Magnetic Albumin Nanoparticles via a Simple and One-pot Desolvation and Co-precipitation Method for Medical and Pharmaceutical Ap-plications[J]. International Journal of Biological Macromolecules, 2018, 108: 909-915.

[2] Zhu D, Tao W, Zhang H, et al. Docetaxel (DTX)-loaded Polydopamine-modified TPGS-PLA Nanoparticles as a Targeted Drug Delivery System for the Treatment of Liver Cancer[J]. Acta Biomaterialia, 2016, 30: 144-154.

[3] Lu CS, Shieh GS, Wang CT, et al. Chemotherapeutics-induced Oct4 Expression Contributes to Drug Resistance and Tumor Recurrence in Bladder Cancer[J]. Oncotarget, 2017, 8(19): 30 844

[4] Ge F, Qiao R, Song P, et al. Construction of the Targeted and pH-sensitive Paclitaxel Drug Delivery System RGD/PTX@ZIF-90 and Anti-tumor Activity Research[J]. Materials Research Express, 2021, 8(4): 45 012-45 019.

[5] Wang J, Liu LG, Jiao WQ, et al. Phenylboronic Acid-conjugated Chitosan Nanoparticles for High Loading and Efficient Delivery of Cur-cumin[J]. Carbohydrate Polymers, 2020, 256(3): 117 497

[6] Zhang G, Zhu Y, Wang Y, et al. pH/redox Sensitive Nanoparticles with Platinum (iv) Prodrugs and Doxorubicin Enhance Chemotherapy in Ovarian Cancer[J]. RSCAdvances, 2019, 9(36): 20 513-20 517.

[7] Mu X, Zhang M, Wei A, et al. Doxorubicin and PD-L1 siRNA Co-delivery with Stem Cell Membrane-coated Polydopamine Nanoparticles for the Targeted hemoimmunotherapy of PCa Bone Metastases[J]. Nanoscale, 2021, 13(19): 8 998-9 008.

[8] Ma H, Zhang X, Pang L, et al. Mn-dox Metal-organic Nanoparticles for Cancer Therapy and Magnetic Resonance Imaging[J]. Dyes and Pigments, 2022, 199: 110 080.

[9] Kirtane AR, Verma M, Karandikar P, et al. Nanotechnology Approaches for Global Infectious Diseases[J]. Nature Nanotechnology, 2021, 16(4): 369-384.

[10] Wu X, Hu W, Lu L, et al. Repurposing Vitamin D for Treatment of Human Malignancies via Targeting Tumor Microenvironment[J]. Acta Pharmaceutica Sinica B, 2019, 9(2): 203-219.

[11] Zhang J, Shi Z, Xu X, et al. The Influence of Microenvironment on Tumor Immunotherapy[J]. Wiley-Blackwell Online Open, 2019, 286(21): 4 160-4 175.

[12] Chen C, Bai L, Cao F, et al. Targeting LIN28B Reprograms Tumor Glucose Metabolism and Acidic Microenvironment to Suppress Cancer Stemness and Metastasis[J]. Oncogene, 2019, 38(23): 4 527-4 539.

[13] Liu LF, D Arpa P. Topoisomerase-targeting Antitumor Drugs: Mechanisms of Cytotoxicity and Resistance[J]. Important Advances in Oncology, 1992: 79–89

[14] Zhou Z, Zhong C, Su D, et al. Synthesis, Antitumor Activity and Molecular Mechanism of Doxorubicin Conjugated Trimethyl-chitosan Polymeric Micelle Loading Beclin1 siRNA for Drug-resisted Bladder Cancer Therapy[J]. RSC Adv., 2018, 8(62): 35 395-35 402.

[15] Sohail M, Sun Z, Li Y, et al. Research Progress in Strategies to Improve the Efficacy and Safety of Doxorubicin for Cancer Chemothera-py[J]. Expert Review of Anticancer Therapy, 2021, 21(12): 1 385-1 398.

[16] Huang XX, Chi JF, Guo HY. Research Progress of Exosomes in the Treatment of Doxorubicin-related Cardiotoxicity[J]. Zhonghua Nei Ke Za Zhi [Chinese Journal of Internal Medicine], 2021, 60(4): 380-383.

[17] Feng H, Kang JH, Qi S, et al. Preparation of a PEGylated Liposome that Co-encapsulates l-arginine and Doxorubicin to Achieve a Synergistic Anticancer Effect[J]. RSC Adv., 2021, 11(54): 34 101-34 106.

[18] Chen F, Zhao Y, Pan Y, et al. Synergistically Enhanced Therapeutic Effect of a Carrier-Free HCPT/DOX Nanodrug on Breast Cancer Cells through Improved Cellular Drug Accumulation[J]. Molecular Pharmaceutics, 2015, 12(7): 2 237-2 244.

[19] Huang D, Zhou Y, Xiang Y, et al. Polyurethane/Doxorubicin Nanoparticles based on Electrostatic Interactions as pH-sensitive Drug Delivery Carriers[J]. Polymer International, 2018, 67(9): 1 186-1 193.

[20] Saboktakin MR, Tabatabaie RM, Maharramov A, et al. Synthesis and in vitro Evaluation of Carboxymethyl Starch-chitosan Nanoparticles as Drug Delivery System to the Colon[J]. International Journal of BiologicalMacromolecules, 2011, 48(3): 381-385.

[21] Fu D, Han B, Dong W, et al. Effects of Carboxymethyl Chitosan on the Blood System of Rats[J]. Biochemical and Biophysical Research Communications, 2011, 408(1): 110-114.

[22] Zheng M, Han B, Yang Y, et al. Synthesis, Characterization and Biological Safety of O-carboxymethyl Chitosan used to Treat Sarcoma 180 Tumor[J]. Carbohydrate Polymers, 2011, 86(1): 231-238.

[23] Li D, Lu B, Huang Z, et al. A Novel Melphalan Polymeric Prodrug: Preparation and Property Study[J]. Carbohydrate Polymers, 2014, 111: 928-935.

[24] Wang W, Meng Q, Li Q, et al. Chitosan Derivatives and Their Application in Biomedicine[J]. International Journal of Molecular Sciences, 2020, 21(2): 487

[25] Naskar S, Sharma S, Kuotsu K. Chitosan-based Nanoparticles: An Overview of Biomedical Applications and its Preparation[J]. Journal of Drug Delivery Science and Technology, 2019, 49: 66-81.

[26] Chen G, Wei P, Huang L, et al. pH-responsive Hyaluronic Acid Nanoparticles Co-delivering DOX and ICG for Effectively Chemo-photothermal Combination Therapy[J]. Journal of Nanoparticle Research, 2021, 23(11): 1-13.

[27] Clogston JD, Patri A K. Zeta Potential Measurement[J]. Characterization of Nanoparticles Intended for Drug Delivery, 2011: 63–70

[28] Raveendran R, Bhuvaneshwar G S, Sharma C P. Hemocompatible Curcumin-dextran Micelles as pH Sensitive Pro-drugs for Enhanced Therapeutic Efficacy in Cancer Cells[J]. Carbohydrate Polymers, 2016, 137: 497-507.

[29] Zhang Y, Li K, Chen H, et al. Agglomeration of Ultra-fine Particles from Flue Gas in Coal-fired Power Plant using Polymeric Floccu-lants[C]. In: 2016 International Conference on Civil, Structure and Environmental Engineering. Atlantis Press, 2016: 151–155

[30] Wang C, Ren G, Wei K, et al. Improved Dispersion Performance and Interfacial Compatibility of Covalent-grafted MOFs in Mixed-matrix Membranes for Gas Separation[J]. Green Chemical Engineering, 2021, 2(1): 10

[31] Hristov DR, Lopez H, Ortin Y, et al. Impact of Dynamic Sub-populations within Grafted Chains on the Protein Binding and Colloidal Stability of PEGylated Nanoparticles[J]. Nanoscale, 2021, 13(10): 5 344-5 355.

[32] Pownall HJ, Liu J, Gillard BK, et al. Physico-chemical and Physiological Determinants of Lipo-nanoparticle Dtability[J]. Nanomedicine Nanotechnology Biology and Medicine, 2021(1): 102 361

[33] Luo Z, Jiang J. pH-sensitive Drug Loading/Releasing in Amphiphilic Copolymer PAE-PEG: Integrating Molecular Dynamics and Dissipative Particle Dynamics Simulations[J]. Journal of Controlled Release, 2012, 162(1): 185-193.

[34] Enjavi Y, Sedghamiz MA, Rahimpour MR. Application of Nanofluids in Drug Delivery and Disease Treatment[M]. Nano luids and Mass Transfer. Elsevier, 2022: 449–465

[35] Gao M, Chen C, Fan A, et al. Stimuli-responsive Polymer-curcumin Conjugate Micelles: Residual Cytotoxicity Analysis[J]. Nanomedicine: Nanotechnology, Biology and Medicine, 2016, 12(2): 468

[36] Zhou H, Xu H, Xin L, et al. Dual Targeting Hyaluronic Acid-RGD Mesoporous Silica Coated Gold Nanorods for Chemo-photothermal Cancer Therapy[J]. Materials Science & Engineering C Materials for Biological Applications, 2017, 81(dec.): 261